SCHEMBL546446

SCHEMBL546446

Cc1cccc2occc(=O)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.48
MAOA P21397 3/20 0.48
FTO Q9C0B1 2/20 0.48
ADORA2A P29274 1/20 0.41
ELANE P08246 3/20 0.41
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
ATM Q13315 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.34
PARP1 P09874 1/20 0.33
GAA P10253 1/20 0.33
KCNA3 P22001 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29568413 1.00 MAOB (0.48) MAOBMAOAFTOADORA2AELANE
SCHEMBL11412674 0.78 MAOB (0.50) MAOBMAOAFTOKDM4ELMNA
SCHEMBL29960477 0.76 AR (0.49) MAOBMAOAFTOKDM4ELMNA
SCHEMBL10504356 0.76 MAOB (0.48) MAOBMAOAFTOKDM4ELMNA
SCHEMBL30111795 0.76 HTR2B (0.50) MAOBMAOAFTOKDM4EATM
SCHEMBL1857840 0.76 HTR2B (0.50) MAOBMAOAFTOKDM4EATM
SCHEMBL1859617 0.76 MAOB (0.59) MAOBMAOAFTOKDM4ELMNA
SCHEMBL29959798 0.76 MAOB (0.59) MAOBMAOAFTOKDM4ELMNA
SCHEMBL20886870 0.72 MAPT (0.53) MAOAELANEKDM4ELMNAATM
SCHEMBL30087046 0.72 MAPT (0.53) MAOAELANEKDM4ELMNAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195435-B2 5-methylchromone and the preparation method and application thereof HAINAN MEDICAL UNIVERSITY (CN) 2025-01-14 US claimed
CN-112174922-B 5-methyl primary ketone and preparation method and application thereof 海南医学院 2023-07-11 CN claimed
CN-113527244-B 5-methyl chromone derivative and synthetic method and application thereof 海南医学院 2023-02-03 CN claimed
US-20220324824-A1 A 5-METHYLCHROMONE AND THE PREPARATION METHOD AND APPLICATION THEREOF HAINAN MEDICAL UNIVERSITY (CN) 2022-10-13 US claimed
CN-113527244-A 5-methyl chromone derivative and synthetic method and application thereof 海南医学院 2021-10-22 CN claimed
CN-112174922-A 5-methyl chromone and preparation method and application thereof 海南医学院 2021-01-05 CN claimed
US-12195435-B2 5-methylchromone and the preparation method and application thereof HAINAN MEDICAL UNIVERSITY (CN) 2025-01-14 US disclosed
US-12195435-B2 5-methylchromone and the preparation method and application thereof HAINAN MEDICAL UNIVERSITY (CN) 2025-01-14 US disclosed
US-12195435-B2 5-methylchromone and the preparation method and application thereof HAINAN MEDICAL UNIVERSITY (CN) 2025-01-14 US disclosed
CN-117777119-A Method for extracting and purifying aloesin from aloe product 高陵蓝晓科技新材料有限公司 2024-03-29 CN disclosed
US-11857657-B2 Diarylalkanes as potent inhibitors of binuclear enzymes UNIGEN, INC. (US) 2024-01-02 US disclosed
CN-112174922-B 5-methyl primary ketone and preparation method and application thereof 海南医学院 2023-07-11 CN disclosed
US-20230142062-A1 THE APPLICATION OF ALOESIN IN THE PREPARATION OF PRODUCTS FOR PREVENTING OR TREATING OBESITY HAINAN MEDICAL UNIVERSITY (CN) 2023-05-11 US disclosed
WO-1998052934-A1 METHOD FOR THE SYNTHESIS OF 8-C-β-D-[2'-O-(E)-CINNAMOYL] GLYCOPYRANOSYL-2-[2-HYDROXY] PROPYL-7-METHOXY-5-METHYLCHROMONE UNIVERA PHARMACEUTICALS, INC. (US) 1998-11-26 WO disclosed
US-5801256-A Method for the synthesis of 8-C-β-D 2'-O-(E)-cinnamoyl!glycopyranosyl-2- 2-hydroxy!propyl-7-methoxy-5-methylchromone UNIVERA PHARMACEUTICALS, INC. (US) 1998-09-01 US disclosed
US-5801256-A Method for the synthesis of 8-C-β-D 2'-O-(E)-cinnamoyl!glycopyranosyl-2- 2-hydroxy!propyl-7-methoxy-5-methylchromone UNIVERA PHARMACEUTICALS, INC. (US) 1998-09-01 US disclosed
EP-0817636-A4 CINNAMOYL-C-GLYCOSIDE CHROMONE ISOLATED FROM ALOE BARBADENSIS UNIVERA PHARM INC (US) 1998-05-06 EP disclosed
EP-0817636-A1 CINNAMOYL-C-GLYCOSIDE CHROMONE ISOLATED FROM ALOE BARBADENSIS Univera Pharmaceuticals, Inc. (US) 1998-01-14 EP disclosed
WO-1996040182-A1 IDENTIFICATION OF A POTENT ANTIOXIDANT FROM ALOE BARBADENSIS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1996-12-19 WO disclosed
WO-1996025937-A1 CINNAMOYL-C-GLYCOSIDE CHROMONE ISOLATED FROM ALOE BARBADENSIS UNIVERA PHARMACEUTICALS, INC. (US) 1996-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12195435-B2 5-methylchromone and the preparation method and application thereof TYR, DHCR7, CYP46A1 MAOB 22/4885MAOA 26/4885FTO 74/4885
US-20220324824-A1 A 5-METHYLCHROMONE AND THE PREPARATION METHOD AND APPLICATION THEREOF TYR, DHCR7, CYP51A1 MAOB 24/4885MAOA 23/4885FTO 70/4885
US-11857657-B2 Diarylalkanes as potent inhibitors of binuclear enzymes TYR, DDT, HAAO MAOB 18/4885MAOA 7/4885FTO 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.